Episode 12

GENEPRODX

Top facts

GeneproDX is transforming traditional medicine — bridging Health Tech and AI and providing patients with fast, reliable, and accurate diagnostics..

genepro_dx_logo.png

Business industry:Healthcare

Number of employees:Fewer than 10

Business type:B2B

Years In business:5-9

Our advantage

GeneproDX is bringing cutting-edge diagnostics to patients by providing the first and only globally available diagnostic test for patients with indeterminate thyroid nodules (ThyroidPrint). We will offer a seamless sample-to-insight testing in under 48 hours by using a globally Idylla available diagnostic platform, providing access to hundreds of thousands of underserved patients around the world.

Summary

GeneproDX is transforming traditional medicine — bridging Health Tech and AI and providing patients with fast, reliable, and accurate diagnostics. GeneproDX’s patented product, ThyroidPrint, is widely used by doctors in Latin America with plans for expansion to the U.S. and Europe in 2022. ThyroidPrint provides highly-accurate diagnosis, resulting in fewer unnecessary surgeries — saving patients from life-altering surgical outcomes.

Have a Question?

We would love to help.

340
Join our Newsletter and never miss our latest news

potential unicorns

news

Potential investors, prior to subscribing to the securities described here in, should read the offering memorandum related to these securities, and all risk factors and exhibits therein in their entirety. The securities described in the offering memorandum involve a high degree of risk, and returns, including return of capital, are not guaranteed. An offer of our securities is made solely by the offering memorandum, which does not constitute an offer to anyone in any country or state in which such offer or solicitation is not authorized, or to any person to whom it is unlawful to make such an offer or solicitation

© 2020 - 2024 Unicorn Hunters.com. All Rights Reserved

We'd like to use cookies to understand your use of our website. To find out more about cookies and how to change your choices, please go to our .